-
2022-500319-38-00
4
2024-05-03
Paroxysmal supraventricular tachycardia (PSVT)
-
2024-515044-23-01
4
2024-04-29
Chronic right heart failure
-
2023-510506-41-00
4
2024-04-15
Locally advanced, unresectable non-small-cell lung cancer (NSCLC)
(Sta
-
2022-502432-39-00
1
2024-04-10
Pelizaeus-Merzbacher Disease
-
2023-504323-25-01
5
2024-03-19
breast cancer
-
2023-508502-18-00
5
2024-03-19
Alport syndrome
-
2023-503558-10-00
5
2023-10-13
oligometastatic pancreatic cancer
-
2022-502851-79-00
5
2023-09-20
Active Idiopathic Inflammatory Myopathy (IIM)
-
2022-503133-54-00
7
2023-08-09
Solid Tumors
-
2024-512320-11-00
5
2023-08-09
Primary diffuse large B-cell lymphoma of the central nervous system
(P
-
2024-517966-40-00
4
2023-07-13
Acute lymphoblastic leukemia (ALL), de novo, Ph/BCR::ABL1 positive (Ph
-
2022-500783-35-00
5
2022-12-06
Acute Myeloid Leukemia
-
2023-508425-28-00
4
2022-10-24
Chronic Inflammatory Demyelinating Polyneuropathy
-
2022-500764-35-00
6
2022-10-13
Patients with advanced HER2-negative, hormone receptor positive (HER2n
-
2022-500107-50-00
6
2022-10-12
hilar cholangiocarcinoma
-
2023-509278-41-00
5
2022-07-04
Early Stage Follicular LymphOma
-
2022-501180-40-00
5
2022-06-17
Ewing Sarcoma
-
2023-510353-42-00
7
2022-02-21
Myotonic Dystrophy Type 1
-
2023-508963-58-00
4
2022-01-31
Symptomatic hypertrophic cardiomyopathy (HCM)
-
2023-504152-97-00
5
2021-11-26
Generalized Myasthenia Gravis
-
2024-512174-10-00
5
2021-11-11
metastatic colorectal cancer
-
2024-510578-25-00
5
2021-11-05
Histologically proven high-risk medulloblastoma, with any of the curre
-
2024-512953-26-00
5
2021-07-06
intermediate-stage hepatocellular carcinoma
-
2024-515708-38-01
7
2021-01-29
Heart failure